JSC
ZBH icon

Jackson Square Capital’s Zimmer Biomet ZBH Stock Holding History

Jackson Square Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-338
Closed -$45K – 339
2020
Q3 		$45K Hold
338
– – 0.02% 178
2020
Q2 		$39K Hold
338
– – 0.02% 166
2020
Q1 		$33K Hold
338
– – 0.03% 142
2019
Q4 		$49K Buy
+338
New +$46.7K 0.03% 152

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Jackson Square Capital's ZBH Position: Q4 2020 in Review

Jackson Square Capital sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 338 shares — an estimated $45K sold.

Jackson Square Capital first reported a position in ZBH in Q4 2019 and held it in 4 quarters. The position peaked at $49K in Q4 2019. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Jackson Square Capital reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Jackson Square Capital sold 338 Zimmer Biomet shares in Q4 2020, an estimated $45K.
  • Jackson Square Capital first reported a position in Zimmer Biomet in Q4 2019 and held it in 4 quarters.
  • Jackson Square Capital's Zimmer Biomet position peaked at $49K in Q4 2019.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.